DE1171434B - Verfahren zur Herstellung eines geschmackfreien Salzes des 3-(5'-Nitrofurfuryliden-amino)-5-(morpholino-methyl)-oxazolidons-(2) - Google Patents

Verfahren zur Herstellung eines geschmackfreien Salzes des 3-(5'-Nitrofurfuryliden-amino)-5-(morpholino-methyl)-oxazolidons-(2)

Info

Publication number
DE1171434B
DE1171434B DEN20129A DEN0020129A DE1171434B DE 1171434 B DE1171434 B DE 1171434B DE N20129 A DEN20129 A DE N20129A DE N0020129 A DEN0020129 A DE N0020129A DE 1171434 B DE1171434 B DE 1171434B
Authority
DE
Germany
Prior art keywords
salt
amino
morpholino
methyl
nitrofurfurylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEN20129A
Other languages
German (de)
English (en)
Inventor
Claude Franklin Spencer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Publication of DE1171434B publication Critical patent/DE1171434B/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DEN20129A 1960-07-12 1961-06-02 Verfahren zur Herstellung eines geschmackfreien Salzes des 3-(5'-Nitrofurfuryliden-amino)-5-(morpholino-methyl)-oxazolidons-(2) Pending DE1171434B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4220560A 1960-07-12 1960-07-12

Publications (1)

Publication Number Publication Date
DE1171434B true DE1171434B (de) 1964-06-04

Family

ID=21920621

Family Applications (1)

Application Number Title Priority Date Filing Date
DEN20129A Pending DE1171434B (de) 1960-07-12 1961-06-02 Verfahren zur Herstellung eines geschmackfreien Salzes des 3-(5'-Nitrofurfuryliden-amino)-5-(morpholino-methyl)-oxazolidons-(2)

Country Status (5)

Country Link
CH (1) CH390254A (xx)
DE (1) DE1171434B (xx)
ES (1) ES268449A1 (xx)
FR (2) FR1590053A (xx)
NL (1) NL266216A (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE188696T1 (de) * 1991-08-14 2000-01-15 Procter & Gamble Pharma Oxazolidinon-derivate mit antiarrhythmischer und antifibrillatorische wirkung
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802002A (en) * 1956-07-18 1957-08-06 Norwich Pharma Co Series of new nu-(5-nitro-2-furyl) alkylidene-3-amino-5-tertiaryamino-methyl-2-oxazolidones and the preparation thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802002A (en) * 1956-07-18 1957-08-06 Norwich Pharma Co Series of new nu-(5-nitro-2-furyl) alkylidene-3-amino-5-tertiaryamino-methyl-2-oxazolidones and the preparation thereof

Also Published As

Publication number Publication date
FR1452M (fr) 1962-08-20
FR1590053A (xx) 1970-04-13
CH390254A (de) 1965-04-15
NL266216A (xx)
ES268449A1 (es) 1961-12-01

Similar Documents

Publication Publication Date Title
DE1445186C3 (de) 3,3'-Di-2-imidazolin-2-yl-carbanilid
DE1159937B (de) Verfahren zur Herstellung von Hydrindensulfonylharnstoffen
DE2458638A1 (de) Propiophenonderivate und deren herstellung
DE1171434B (de) Verfahren zur Herstellung eines geschmackfreien Salzes des 3-(5'-Nitrofurfuryliden-amino)-5-(morpholino-methyl)-oxazolidons-(2)
DE1191826B (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide und ihrer Salze
AT224633B (de) Verfahren zur Herstellung eines neuen Salzes des 3-(5'-Nitrofurfuryliden-amino)-5-(N-morpholinyl-methyl)-2-oxazolidons
DE2005104C2 (de) 1-Alkyl-6,7-methylendioxy-4(1H)-oxocinnolin-3-carbonsäuren und Verfahren zu ihrer Herstellung
DE2617198C2 (de) 6-n-Propoxybenzthiazol-2-methylcarbamat, Verfahren zu seiner Herstellung und es enthaltende Arzneimittel
DE1177633B (de) Verfahren zur Herstellung aminoalkylierter 9,10-Dihydroanthracene
DE1147588B (de) Verfahren zur Herstellung des bakterizid wirksamen 2-[1-(5-Nitrofurfuryliden-amino)-2, 4-dioxo-imidazolidyl-(3)]-aethyl-carbaminsaeure-aethylesters
DE1670378C (de) Verfahren zur Herstellung des Salzes aus4-n-Butyl-3,5-dioxo-l,2-diphenylpyrazolidin und dem beta-Diäthylamino-äthylamid der p-Chlorphenoxyessigsäure
AT236406B (de) Verfahren zur Herstellung von neuen Azidobenzolsulfonylharnstoffen
DE1695689C3 (de) 3- (5-Nitro-2-thenylidenamino) -oxazolidon- (2) -derivate
DE1227462B (de) Verfahren zur Herstellung von Chinolinderivaten
DE1177645B (de) Verfahren zur Herstellung von kondensierten heterocyclischen Verbindungen
AT236975B (de) Verfahren zur Herstellung von neuen Azidobenzolsulfonylharnstoffen
DE1618160C3 (de) l-(2-Äthinylphenoxy)-2-hydroxy-3alkylaminopropane, ihre physiologisch verträglichen Säureadditionssalze, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel
DE1793628C (de) Erythromycinoxim und Verfahren zu dessen Herstellung
DE2051429C3 (de) Desacetylaranotin und ein Verfahren zu seiner Herstellung. Änm: Eli Lilly and Co., Indianapolis, Ind. (V.StA.)
DE1237125B (de) Verfahren zur Herstellung des antimikrobiell wirksamen 5-Acetylimino-3-(5-nitro-2-furyl)-delta 2-1, 2, 4-triazolins
DE1595891C3 (de) 6-(ß-Dimethylaminopropyl)-pyrido- [2,3-b] [1, 5] benzodiazepin- (6H) -on-5, deren Salze und Verfahren zu ihrer Herstellung
DE1695571A1 (de) 3-Amino-2-imino-4-(5-nitro-2-furyl)-delta4-thiazolin bzw. seine Salze und Verfahren zu ihrer Herstellung
DE1203781B (de) Verfahren zur Herstellung von trypanocid wirksamen Phenanthridiniumderivaten
DE1166784B (de) Verfahren zur Herstellung von Sulfanilamidopyrazolen
DE1190945B (de) Verfahren zur Herstellung von 3-Methoxymethyl-1-(5'-nitrofurfuryliden-amino)-hydantoin